NEWSROOM Semaglutide (Ozempic) use during breastfeeding concerns related to rapid weight loss, not the drug itself Science to practice Latest highlights on drug safety and efficacy 1.4.2025 Semaglutide (Ozempic) is a glugacon-like peptide-1 (GLP-1) analogue, indicated for treatment of type 2 diabetes, and increasingly used for treating obesity
One of the studies it examined, from 2020, found that 67 percent of its sample were obese, of whom 15 percent died as a result of infection
Both semaglutide and intermittent fasting have the potential to promote healthy weight management
Weight loss results from the ensuant reduction in calorie consumption
Why Gradual Titration Matters Higher doses of retatrutide tend to produce stronger effects on appetite and metabolism, but they can also increase the likelihood of side effects if escalated too quickly
A weekly injection of B Vitamins, Lipotrim or MIC can be a great addition to your weight loss journey